Deal Details

H.I.G. Acquires ITH

Healthcare

H.I.G. acquisition of ITH

Summary

An affiliate of H.I.G. Capital (“H.I.G.”) has acquired ITH Group Limited (“ITH” or the “Company”). Terms of the transaction were not disclosed.

Baird served as exclusive financial advisor to H.I.G. on this transaction.

About

H.I.G. is a leading global alternative investment firm with $70 billion of capital under management.* Based in Miami, and with offices in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco and Stamford in the United States, as well as international affiliate offices in Hamburg, London, Luxembourg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro, São Paulo, Dubai and Hong Kong, H.I.G. specializes in providing both debt and equity capital to mid-sized companies, utilizing a flexible and operationally focused/value-added approach. Since its founding in 1993, H.I.G. has invested in and managed more than 400 companies worldwide. The firm's current portfolio includes more than 100 companies with combined sales in excess of $53 billion.

ITH was founded in 2008. With facilities in London, United Kingdom, ITH specialises in the provision of aseptic compounding services for NHS and private customers, with a particular focus on chemotherapy, total parenteral nutrition and central intravenous additive services. The Company also operates a leading digital pharmacy that provides critical, licensed medication to private and NHS patients.

*Based on total capital raised by H.I.G. Capital and its affiliates.

Healthcare

H.I.G. acquisition of ITH